Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.

Focal necrosis is a key pathologic feature that distinguishes glioblastoma from lower grade glioma. The presence of necrosis in a glioblastoma could promote its rapid growth and clinical progression. Focal necrosis of glioblastoma seems to be associated with thrombosis that result from hyper-coagulability. In the present study, we found that glioblastoma cells had a high level of constitutive nuclear factor (NF)-kappaB activity, which was directly correlated with necrosis in glioblastomas. We also found a direct correlation between NF-kappaB activity and the expression of tissue factor (TF), a potent procoagulant factor in gliomas. Inhibition of TF by an inhibitory antibody prevented the procoagulant activity of glioblastoma cells, indicating a TF-dependent mechanism. Blockade of NF-kappaB activation significantly inhibited TF expression and the procoagulant activity of glioblastoma cells in vitro. Blockade of NF-kappaB activation also significantly inhibited in vivo expression of TF, which was directly correlated with decreased necrosis formation and tumor growth of glioblastoma cells in nude mice. Collectively, these results suggest that elevated NF-kappaB activity in glioblastomas cells plays a critical role in necrosis formation of glioblastoma and that inhibition of NF-kappaB activity in glioblastoma can suppress necrosis formation and progressive growth.

[1]  Chuanshu Huang,et al.  VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-κB signaling pathway , 2006, Respiratory research.

[2]  Masatsugu Horiuchi,et al.  London Radiation Symposium , 1963, Cell and tissue kinetics.

[3]  K. Aldape,et al.  Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer , 2005, Clinical Cancer Research.

[4]  Erwin G. Van Meir,et al.  PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. , 2005, Cancer research.

[5]  P. Black,et al.  In vitro and In vivo Activity of the Nuclear Factor-κB Inhibitor Sulfasalazine in Human Glioblastomas , 2004, Clinical Cancer Research.

[6]  G. Fuller,et al.  Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas , 2004, Laboratory Investigation.

[7]  Daniel J Brat,et al.  Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma , 2004, Laboratory Investigation.

[8]  E. Parati,et al.  Genetic and Plasma Markers of Venous Thromboembolism in Patients with High Grade Glioma , 2004, Clinical Cancer Research.

[9]  K. Hess,et al.  Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis , 2004, Clinical Cancer Research.

[10]  Faith Davis,et al.  Brain tumor survival: Results from the National Cancer Data Base , 1998, Journal of Neuro-Oncology.

[11]  Raymond Sawaya,et al.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme , 2004, Journal of Neuro-Oncology.

[12]  M. Levine,et al.  Venous Thromboembolism and Cancer: Risks and Outcomes , 2003, Circulation.

[13]  S. Leibovich,et al.  Regulation of Vascular Endothelial Growth Factor Gene Expression in Murine Macrophages by Nitric Oxide and Hypoxia , 2003, Experimental biology and medicine.

[14]  M. Kibbe,et al.  Regulation of tissue factor expression in smooth muscle cells with nitric oxide. , 2003, Journal of vascular surgery.

[15]  Raymond Sawaya,et al.  Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis , 2002, Neurosurgery.

[16]  T. Kumanishi,et al.  Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma. , 2002, Journal of neurosurgery.

[17]  S. Westerheide,et al.  PTEN Blocks Tumor Necrosis Factor-induced NF-κB-dependent Transcription by Inhibiting the Transactivation Potential of the p65 Subunit* , 2002, The Journal of Biological Chemistry.

[18]  N. Mackman,et al.  Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. , 2001, Blood.

[19]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[20]  Marty W. Mayo,et al.  Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38* , 2001, The Journal of Biological Chemistry.

[21]  C. Bucana,et al.  Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. , 2001, Oncogene.

[22]  N. Maulik,et al.  Oxidative stress due to hypoxia/reoxygenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NFkappaB. , 2000, Toxicology.

[23]  C. Bucana,et al.  Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. , 2000, Cancer research.

[24]  G. Fuller,et al.  An implantable guide-screw system for brain tumor studies in small animals. , 2000, Journal of neurosurgery.

[25]  C. Bucana,et al.  Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[27]  J. Romashkova,et al.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.

[28]  J. Abbruzzese,et al.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  M. Tainsky,et al.  Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasis , 1998, The EMBO journal.

[30]  A. Falanga.  Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy , 1998, Pathophysiology of Haemostasis and Thrombosis.

[31]  S. Dower,et al.  Response of tumour cells to hypoxia: role of p53 and NFkB. , 1998, Molecular pathology : MP.

[32]  J. Jesty,et al.  Vascular endothelial groth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatininase a activation and cell proliferation , 1998, International journal of cancer.

[33]  C. Der,et al.  Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.

[34]  J. Kuratsu,et al.  Expression of tissue factor correlates with grade of malignancy in human glioma , 1996, Cancer.

[35]  Susan M. Chang,et al.  Necrosis as a prognostic factor in glioblastoma multiforme , 1996, Cancer.

[36]  D. Green,et al.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB. , 1996, Science.

[37]  N. Mackman.  Regulation of the tissue factor gene , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  N. Mackman,et al.  Transcriptional regulation of tissue factor expression in human endothelial cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[39]  A. Koong,et al.  Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). , 1994, Cancer research.

[40]  C. Rosen,et al.  Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site , 1994, Molecular and cellular biology.

[41]  A. Wyllie,et al.  Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. , 1994, The American journal of pathology.

[42]  A. Koong,et al.  Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. , 1994, Cancer research.

[43]  R. Hellman,et al.  Venous Thromboembolism and High Grade Gliomas , 1993, Thrombosis and Haemostasis.

[44]  Goldman,et al.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. , 1993, Molecular biology of the cell.

[45]  E. Alvord.  Is Necrosis Helpful in the Grading of Gliomas? Editorial Opinion , 1992, Journal of neuropathology and experimental neurology.

[46]  H. Dvorak,et al.  Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.